Moneycontrol
Get App
Last Updated : Apr 01, 2019 02:57 PM IST | Source: Moneycontrol.com

Lupin jumps 4% after launch of erectile dysfunction drug

Tadalafil is the generic equivalent of Eli Lilly and company's Cialis tablets

Moneycontrol News @moneycontrolcom
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Lupin shares rallied more than 4 percent intraday on April 1 after the company launched Tadalafil tablet that treats erectile dysfunction.

The stock was quoting at Rs 769.80, up Rs 30.70, or 4.15 percent on the BSE, at 1442 hours IST.

After the approval from the US Food and Drug Administration, the pharma major launched Tadalafil tablets USP, 2.5 mg, 5 mg, 10 mg, and 20 mg in the US.

Tadalafil is the generic equivalent of Eli Lilly and company's Cialis tablets.

The drug is indicated for the treatment of erectile dysfunction (ED), and the signs and symptoms of benign prostatic hyperplasia (BPH).

Lupin said Tadalafil had annual sales of approximately $1,780 million in the US, as per IQVIA MAT December 2018.
First Published on Apr 1, 2019 02:57 pm
More From
Loading...
Sections
Follow us on
Available On
PCI DSS Compliant